- $687.44m
- $625.13m
- $52.23m
Annual income statement for Brainsway, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.7 | 27.2 | 31.8 | 41 | 52.2 |
| Cost of Revenue | |||||
| Gross Profit | 23.1 | 20 | 23.5 | 30.6 | 39.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 34.7 | 39.9 | 36.7 | 39.6 | 47.9 |
| Operating Profit | -5 | -12.7 | -4.96 | 1.39 | 4.32 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.42 | -13 | -3.95 | 3.46 | 7.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.46 | -13.3 | -4.2 | 2.92 | 7.58 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.46 | -13.3 | -4.2 | 2.92 | 7.58 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.46 | -13.3 | -4.2 | 2.92 | 7.58 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.207 | -0.405 | -0.127 | 0.084 | 0.191 |
| Dividends per Share |